๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
North China Pharmaceutical Company.Ltd (SHA:600812)
China flag China ยท Delayed Price ยท Currency is CNY
4.230
-0.160 (-3.64%)
Nov 20, 2026, 3:00 PM CST

SHA:600812 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7,7669,2429,87010,12010,50010,385
Revenue Growth
-20.70%-6.36%-2.48%-3.62%1.11%-9.64%
Gross Profit
2,2682,8783,1383,2133,4373,694
Operating Income
466.6627.16658.87536.44634.8600.11
Net Income
89.44183.06126.994.89-689.2318.73
Earnings Per Share
0.050.110.070.00-0.400.01
EPS Growth
-50.33%44.59%2366.67%---81.67%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Pharmaceutical Intermediates
384.08
Other
120.61
Pharmaceuticals and Other Logistics Trade
633.25
Chemical API
2,289
Chemical Drug Substance
4,098
Biological Agents
1,613
Total
9,138

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,5091,5411,660988.281,6835,305
Total Debt
11,11411,21511,45011,14811,04913,777
Net Cash (Debt)
-9,604-9,674-9,790-10,159-9,366-8,472
Net Cash Growth
------
Net Cash Per Share
-5.65-5.65-5.70-6.23-5.46-4.98

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,2351,1771,2301,0241,0041,050
Capital Expenditures
-538.57-542.01-784.22-623.04-549.58-547.5
Free Cash Flow
696.11634.53445.35401.23454.81502.75
Free Cash Flow Growth
363.24%42.48%11.00%-11.78%-9.54%-

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
29.20%31.15%31.79%31.75%32.73%35.57%
Operating Margin
6.01%6.79%6.68%5.30%6.05%5.78%
Pretax Margin
2.83%3.87%3.14%1.57%-5.38%1.30%
Profit Margin
1.15%1.98%1.29%0.05%-6.56%0.18%
FCF Margin
8.96%6.87%4.51%3.96%4.33%4.84%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0350.0350.0300.010-0.060
Dividend Per Share Growth
16.67%16.67%200.00%--100.00%
Dividend Yield
0.83%0.63%0.58%0.18%-0.50%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
80.3751.8369.851999.79-1092.06
Forward PE
-53.1840.5340.5340.5340.53
P/FCF Ratio
10.4314.9519.9224.3724.1440.68
PS Ratio
0.931.030.900.971.051.97